Human Genome Epidemiology Literature Finder
|
Records 1 - 4 (of 4 Records) |
| Query Trace: Endometrial Neoplasms and CYP3A4[original query] |
|---|
| Estrogen sulfation genes, hormone replacement therapy, and endometrial cancer risk. Journal of the National Cancer Institute 2006 Sep 98 (18): 1311-20. Rebbeck Timothy R, Troxel Andrea B, Wang Yiting, Walker Amy H, Panossian Saarene, Gallagher Stephen, Shatalova Ekaterina G, Blanchard Rebecca, Bunin Greta, DeMichele Angela, Rubin Stephen C, Baumgarten Mona, Berlin Michelle, Schinnar Rita, Berlin Jesse A, Strom Brian |
| Association between CYP3A4 genotype and risk of endometrial cancer following tamoxifen use. Carcinogenesis 2007 Oct 28 (10): 2139-42. Chu William, Fyles Anthony, Sellers Edward M, McCready David R, Murphy Joan, Pal Tuya, Narod Steven |
| Studies on CYP1A1, CYP1B1 and CYP3A4 gene polymorphisms in breast cancer patients. Ginekologia polska 2009 Nov 80 (11): 819-23. Ociepa-Zawal Marta, Rubi? B?azej, Filas Violetta, Breborowicz Jan, Trzeciak Wies?aw |
| A First-in-Human Phase 1 Study of LY3023414, an Oral PI3K/mTOR Dual Inhibitor, in Patients with Advanced Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 2018 4 24 (14): 3253-3262. Bendell Johanna C, Varghese Anna M, Hyman David M, Bauer Todd M, Pant Shubham, Callies Sophie, Lin Ji, Martinez Ricardo, Wickremsinhe Enaksha, Fink Aaron, Wacheck Volker, Moore Kathleen |
- Page last reviewed:Feb 1, 2024
- Content source: